Acute gastrointestinal bleeding as the presenting manifestation of prostate Cancer

Gastrointestinal bleeding was the presenting manifestation in four patients without readily apparent prostate cancer. Three of these patients had laboratory evidence of acute disseminated intravascular coagulation (DIC) and one patient had a friable rectal mass. The diagnosis of prostate cancer was made in three patients by employing an immunoperoxidase technique for prostatic acid phosphatase in metastatic foci. Dramatic resolution of DIC occurred in two patients following hormone therapy. Radiation therapy was effective in controlling bleeding in another patient. Two patients are alive with no further bleeding episodes at 8 and 18 months follow‐up, respectively. In patients who present with a bleeding diathesis and adenocarcinoma of unknown primary, it is important to consider prostate cancer because of its frequent and prolonged responsiveness to hormonal therapy.

[1]  H. G. Taylor,et al.  Atypical Metastasis From Prostate Cancer: Clinical Utility of the Immunoperoxidase Technique for Prostate-Specific Antigen , 1985 .

[2]  S. Goldenberg,et al.  Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy. , 1983, Urology.

[3]  C. Li,et al.  Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin: Immunodiagnosis by prostatic acid phosphatase , 1983, Cancer.

[4]  D. Cornfield,et al.  Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma. , 1982, Southern medical journal.

[5]  G. Murphy,et al.  A prostate antigen in sera of prostatic cancer patients. , 1980, Cancer research.

[6]  W. Swaim,et al.  Disseminated intravascular coagulation in the urologic patient. , 1976, The Journal of urology.

[7]  M. Abeloff,et al.  Spontaneous remission of recurring disseminated intravascular coagulation associated with prostatic carcinoma , 1976, Cancer.

[8]  S. Goodnight BLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY: A REVIEW , 1974, Annals of the New York Academy of Sciences.

[9]  A. Thomas Chronic intravascular coagulation in metastatic prostate cancer , 1973 .

[10]  N. C. Bruns,et al.  Chronic intravascular coagulation in metastatic prostate cancer. , 1973, Archives of surgery.

[11]  P. Straub,et al.  Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin , 1967, Journal of clinical pathology.

[12]  L. L. Phillips,et al.  Manifestation and management of hypofibrinogenemia and firinolysis in patients with carcinoma of the prostate. , 1966, The Journal of urology.

[13]  J. L. Sommer,et al.  Experimental pyelonephritis in the rat with observations on ureteral reflux. , 1961, The Journal of urology.

[14]  L. L. Phillips,et al.  The fibrinolytic enzyme system in prostatic cancer , 1959, Cancer.

[15]  S. Rapaport,et al.  Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. , 1959, The American journal of medicine.

[16]  F. Schilling,et al.  Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases. , 1958, Annals of internal medicine.

[17]  O. Daniel,et al.  Dangerous Bleeding Associated with Carcinoma of Prostate , 1957, British medical journal.

[18]  W. Whitmore,et al.  Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate. , 1953, The American journal of medicine.

[19]  W. Whitmore,et al.  The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate , 1953, Cancer.

[20]  W. Whitmore,et al.  Fibrinolysis in metastatic cancer of the prostate , 1952, Cancer.

[21]  W. Isaacs,et al.  Extracorporeal shock wave therapy decreases COX‐2 by inhibiting TLR4‐NFκB pathway in a prostatitis rat model , 2019, The Prostate.

[22]  A. Little,et al.  Protochemotherapy in non‐small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report , 1986, Cancer.